,Set,N,DE,P.DE,FDR,DEG.GENES
1,WP_PDGF_PATHWAY,39,3,0.000104324288591317,0.0455914630488742,RHOA,VAV1,PDGFB
2,WP_GPCRS_CLASS_A_RHODOPSINLIKE,119,4,0.000173862284040817,0.0455914630488742,FPR3,CCR1,PTGER2,GPR34
3,WP_REGULATION_OF_ACTIN_CYTOSKELETON,121,4,0.000185367814625395,0.0455914630488742,EZR,RHOA,VAV1,PDGFB
4,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,50,3,0.000219717894211442,0.0455914630488742,EZR,RHOA,YWHAQ
5,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,11,2,0.000292133146778242,0.0484941023651881,EZR,RHOA
6,WP_NRF2_PATHWAY,110,3,0.00219205083838833,0.238951160983173,EGR1,FTL,PDGFB
7,WP_OVARIAN_INFERTILITY,30,2,0.00224570966874385,0.238951160983173,PTGER2,EGR1
8,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,31,2,0.00239700043478792,0.238951160983173,RHOA,YWHAQ
9,WP_PEPTIDE_GPCRS,34,2,0.00287892965039967,0.238951160983173,FPR3,CCR1
10,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,34,2,0.00287892965039967,0.238951160983173,BIRC7,PDGFB
11,WP_IL3_SIGNALING,48,2,0.00566896167087896,0.427748926075413,VAV1,YWHAQ
12,WP_FOCAL_ADHESION,173,3,0.00776973179942116,0.537406449459964,RHOA,VAV1,PDGFB
13,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,61,2,0.00902064898964911,0.57593374318529,CR1,YWHAQ
14,WP_AGERAGE_PATHWAY,64,2,0.00989326041160411,0.586529010116529,EZR,RHOA
15,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,5,1,0.0116652169081045,0.626059389844524,EGR1
16,WP_COMPLEMENT_SYSTEM,71,2,0.0120686147439908,0.626059389844524,FCN1,CR1
17,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,1,0.0139822058032003,0.682660636273897,FCN1
18,WP_G_PROTEIN_SIGNALING,80,2,0.0151431719432911,0.698268484051758,RHOA,AKAP5
19,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,7,1,0.0162938712840389,0.711784903460647,RHOA
20,WP_CANCER_PATHWAYS,432,4,0.0183553303935945,0.72838348400384,PTGER2,RHOA,BIRC7,PDGFB
21,WP_SPINAL_CORD_INJURY,90,2,0.0189102084657496,0.72838348400384,EGR1,RHOA
22,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,91,2,0.019306550178415,0.72838348400384,FCN1,CR1
23,WP_OSTEOBLAST_SIGNALING,9,1,0.0209012799037397,0.73436041495216,PDGFB
24,WP_NUCLEAR_RECEPTORS_METAPATHWAY,252,3,0.0212345180227131,0.73436041495216,EGR1,FTL,PDGFB
25,WP_GPCRS_CLASS_B_SECRETINLIKE,10,1,0.0231970469270377,0.755670977287083,ADGRE2
26,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,11,1,0.0254875383050641,0.755670977287083,RHOA
27,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,11,1,0.0254875383050641,0.755670977287083,CHRNA5
28,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,108,2,0.026565190150003,0.755670977287083,EGR1,YWHAQ
29,WP_GASTRIN_SIGNALING,110,2,0.0274816252929634,0.755670977287083,EGR1,RHOA
30,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,1,0.0277727659143285,0.755670977287083,FTL
31,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,14,1,0.0323274772017741,0.755670977287083,RHOA
32,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,14,1,0.0323274772017741,0.755670977287083,PLAC8
33,WP_EBOLA_VIRUS_INFECTION_IN_HOST,123,2,0.033741501643279,0.755670977287083,TIMD4,RHOA
34,WP_IRON_METABOLISM_DISORDERS,15,1,0.0345969845023002,0.755670977287083,FTL
35,WP_KCNQ2RELATED_EPILEPSIES,15,1,0.0345969845023002,0.755670977287083,AKAP5
36,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,15,1,0.0345969845023002,0.755670977287083,RHOA
37,WP_OSTEOCLAST_SIGNALING,15,1,0.0345969845023002,0.755670977287083,PDGFB
38,WP_SMALL_LIGAND_GPCRS,15,1,0.0345969845023002,0.755670977287083,PTGER2
39,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,17,1,0.0391203612776517,0.817634071469176,EGR1
40,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,1,0.0413742542189222,0.817634071469176,YWHAQ
41,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,18,1,0.0413742542189222,0.817634071469176,PDGFB
42,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,18,1,0.0413742542189222,0.817634071469176,RHOA
43,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,19,1,0.0436229657971087,0.842024688641865,CD2
44,WP_CHEMOKINE_SIGNALING,147,2,0.0465854128613777,0.854596000205649,CCR1,VAV1
45,WP_ANGIOGENESIS,21,1,0.0481048915130671,0.854596000205649,PDGFB
46,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,21,1,0.0481048915130671,0.854596000205649,RHOA
47,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,349,3,0.0483927855538138,0.854596000205649,SH3BP4,ENPP2,STON2
48,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,23,1,0.0525662314662085,0.908957752436523,RHOA
49,WP_GENES_CONTROLLING_NEPHROGENESIS,24,1,0.0547892107447955,0.9101605775275,PDGFB
50,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,25,1,0.0570070782872787,0.9101605775275,PTGER2
